Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis
Authors:
- 15 October 2022
- journal article
- review article
- Published by Springer Nature in Translational Stroke Research
- Vol. 14 (6) , 833-841
Abstract
There is increasing interest in drug therapy for preventing aneurysmal subarachnoid hemorrhage (aSAH). We aimed to comprehensively evaluate the association between drug use and the risk of aSAH. We searched PubMed and Scopus from the databases’ inception until December 2021. Observational studies reporting the association between any drug therapy and aSAH were included. The odds ratios (ORs) for each drug used in aSAH were meta-analyzed with a random-effect model. According to the systematic review, 25 observational studies were eligible for the present study. Four therapeutic purpose-based classes (e.g., lipid-lowering agents) and 14 mechanism-based classes (e.g., statins) were meta-analyzed. Anti-hypertensive agents (OR, 0.50; 95% confidence interval [95% CI], 0.33–0.74), statins (OR, 0.55; 95% CI, 0.35–0.85), biguanides (OR, 0.57; 95% CI, 0.34–0.96), and acetylsalicylic acid (ASA) (OR, 0.62; 95% CI, 0.41–0.94) were inversely associated with the risk of aSAH. Non-ASA non-steroidal anti-inflammatory drugs (OR, 1.73; 95% CI, 1.07–2.79), selective cyclooxygenase-2 inhibitors (OR, 2.04; 95% CI, 1.24–3.35), vitamin K antagonists (OR, 1.50; 95% CI, 1.18–1.91), and dipyridamole (OR, 1.77; 95% CI, 1.23–2.54) were positively associated with the incidence of aSAH. There was also a trend toward a positive association between glucocorticoids (OR, 1.38; 95% CI, 0.97–1.94) and aSAH. The present study suggests that anti-hypertensive agents, statins, biguanides, and ASA are candidate drugs for preventing aSAH. By contrast, several drugs (e.g., anti-thrombotic drugs) may increase the risk of aSAH. Thus, the indications of these drugs in patients with intracranial aneurysms should be carefully determined.Keywords
This publication has 42 references indexed in Scilit:
- Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm RuptureStroke, 2011
- PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κBBritish Journal of Pharmacology, 2011
- Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhageJournal of Thrombosis and Haemostasis, 2011
- Antiplatelet drugs and risk of subarachnoid hemorrhage: a population‐based case‐control studyJournal of Thrombosis and Haemostasis, 2010
- Withdrawal of Statins and Risk of Subarachnoid HemorrhageStroke, 2009
- Nonaspirin Nonsteroidal Anti-inflammatory Drugs and Hemorrhagic Stroke RiskStroke, 2008
- Selective Serotonin Reuptake Inhibitors and Risk of Hemorrhagic StrokeStroke, 2007
- Prehemorrhage Risk Factors for Fatal Intracranial Aneurysm RuptureStroke, 2003
- Major Risk Factors for Aneurysmal Subarachnoid Hemorrhage in the Young Are ModifiableStroke, 2003
- Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory DrugsStroke, 2003